Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.